Pharmaceutical antibody compositions with resistance to soluble CEA
Details for Australian Patent Application No. 2006328882 (hide)
International Classifications
Event Publications
5 June 2008 PCT application entered the National Phase
PCT publication WO2007/071422 Priority application(s): WO2007/071422
16 June 2011 Application Accepted
Published as AU-B-2006328882
13 October 2011 Standard Patent Sealed
20 September 2012 Application for Amendment
The nature of the amendment is: Amend the Patentee to read Amgen Research (Munich) GmbH . Address for service in Australia - Griffith Hack GPO Box 1285 Melbourne VIC 3001
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006328886-Pharmaceutical compositions with resistance to soluble CEA
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser